↓ Skip to main content

Cochrane Database of Systematic Reviews

Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children

Overview of attention for article published in Cochrane database of systematic reviews, August 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

twitter
28 tweeters
wikipedia
1 Wikipedia page
f1000
1 research highlight platform

Citations

dimensions_citation
75 Dimensions

Readers on

mendeley
189 Mendeley
citeulike
1 CiteULike
Title
Combined inhaled anticholinergics and short-acting beta2-agonists for initial treatment of acute asthma in children
Published in
Cochrane database of systematic reviews, August 2013
DOI 10.1002/14651858.cd000060.pub2
Pubmed ID
Authors

Benedict Griffiths, Francine M Ducharme

Abstract

There are several treatment options for managing acute asthma exacerbations (sustained worsening of symptoms that do not subside with regular treatment and require a change in management). Guidelines advocate the use of inhaled short acting beta2-agonists (SABAs) in children experiencing an asthma exacerbation. Anticholinergic agents, such as ipratropium bromide and atropine sulfate, have a slower onset of action and weaker bronchodilating effect, but may specifically relieve cholinergic bronchomotor tone and decrease mucosal edema and secretions. Therefore, the combination of inhaled anticholinergics with SABAs may yield enhanced and prolonged bronchodilation.

Twitter Demographics

The data shown below were collected from the profiles of 28 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 189 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 3 2%
Colombia 1 <1%
Canada 1 <1%
Unknown 184 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 31 16%
Researcher 30 16%
Student > Bachelor 25 13%
Other 19 10%
Student > Ph. D. Student 13 7%
Other 42 22%
Unknown 29 15%
Readers by discipline Count As %
Medicine and Dentistry 92 49%
Nursing and Health Professions 18 10%
Pharmacology, Toxicology and Pharmaceutical Science 9 5%
Social Sciences 8 4%
Psychology 5 3%
Other 18 10%
Unknown 39 21%

Attention Score in Context

This research output has an Altmetric Attention Score of 22. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 April 2021.
All research outputs
#1,091,709
of 17,658,188 outputs
Outputs from Cochrane database of systematic reviews
#2,831
of 11,729 outputs
Outputs of similar age
#11,481
of 169,477 outputs
Outputs of similar age from Cochrane database of systematic reviews
#28
of 120 outputs
Altmetric has tracked 17,658,188 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,729 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 25.3. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 169,477 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 120 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.